^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Pancreatic Adenocarcinoma
    Regimen:CAPOX
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Pancreatic Adenocarcinoma: Preferred Regimens…Capecitabine+ Oxaliplatin Pancreatic Adenocarcinoma….PRINCIPLES OF SYSTEMIC THERAPY….Intermediate PS2….Other Recommended Regimens...CapeOx (category 2B)